French questionnaire study for people with rheumatoid arthritis
Part of Bones, joints & muscles clinical trials.
This study checks whether a French questionnaire about rheumatoid arthritis care answers works well. You may help by completing the survey if you have rheumatoid arthritis and meet medication and consent requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older and able to understand the study
- You must sign the consent form and agree freely to join
- You must have health insurance through a covered plan
- You must have rheumatoid arthritis and be on methotrexate (mouth or injections) for at least 3 months
- Your methotrexate dose and how you take it should be stable for at least 1 month, with no planned changes until the second visit
- You must not be in another interventional drug study at the same time
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how young people with rheumatic conditions move from children's doctors to adult doctors. By answering a short questionnaire, you can help improve the transition process for others.
This study looks at how well people with rheumatoid arthritis (RA) take their RA medicines—especially medicines like methotrexate and other targeted or biologic treatments. It may help improve medication adherence (taking doses correctly) and supports safer, more consistent treatment at home.
This study follows different groups of people—from those at high risk of developing rheumatoid arthritis to those recently diagnosed—to learn more about the disease. By joining, you help researchers understand who gets RA and why, which may lead to earlier detection and better care.
This trial studies an add-on treatment approach for rheumatoid arthritis (RA) in adults whose symptoms did not improve with standard “first-line” medicines. It may help people who still have active RA after trying certain disease-modifying drugs.
This study looks at how mood disorders (like depression or anxiety) affect people with chronic inflammatory joint diseases when they use biologic medicines. It may help doctors understand which patients are at higher mood-risk and how to monitor them.
This Phase 4 trial studies whether immune-modulator medicines improve symptoms and function in people with rheumatoid arthritis who have knee problems. It may also compare responses in osteoarthritis and healthy volunteers, depending on the group you fit.
Hear when a new Rheumatoid Polyarthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.